Qu Yuqing, Liu Yang, Wang Xianling, Guo Qinghua, Du Jin, Pei Yu, Ba Jianming, Gu Weijun, Dou Jingtao, Lv Zhaohui, Mu Yiming
Department of Endocrinology The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
Department of Endocrinology Yantai Yuhuangding Hospital, Yantai 264000, Shandong, China.
Int J Endocrinol. 2024 Aug 30;2024:4689745. doi: 10.1155/2024/4689745. eCollection 2024.
This study aimed to analyse the etiology and clinical characteristics of hypercalcemic crisis in a large cohort of Chinese patients and summarised our clinical experience in the management of this serious endocrinological emergency.
This was a retrospective analysis of a cohort of patients with hypercalcemic crisis hospitalized in the First Medical Center of Chinese PLA General Hospital between January 2009 and March 2024. The general data, clinical manifestations, etiology, photographic examination, emergency treatment, etiological treatment, and prognosis were analysed.
A total of 155 patients with hypercalcemic crisis (91 males and 64 females) with a mean age of 54.60 ± 16.99 years old were enrolled. The most frequent disease-causing hypercalcemic crisis was hyperparathyroidism (41.94%), followed by solid malignancy (41.29%) and multiple myeloma (9.03%), et al. Patients mainly presented with symptoms of the digestive system (78.10%), nervous system (63.30%), skeletal system (59.60%), urinary system (59.50%), and cardiovascular system (34.90%). These 155 patients with hypercalcemic crisis got effective therapies that included simultaneous administration of intravenous injection (IV) isotonic saline, subcutaneous calcitonin, bisphosphonate, or hemodialysis in serious cases. After emergency treatment, all the symptoms in the patients were relieved obviously. The cure rate of hypercalcemic with etiological treatments was 84.50% (131/155).
Hypercalcemic crisis is a serious endocrinological emergency with a variety of etiologies and a high risk of mortality. A prompt diagnosis and the implementation of a comprehensive and effective treatment can efficiently alleviate this endocrinological emergency. Etiological treatment targeting different causes can improve prognosis significantly.
本研究旨在分析一大群中国患者高钙血症危象的病因及临床特征,并总结我们在处理这一严重内分泌急症方面的临床经验。
这是一项对2009年1月至2024年3月在中国人民解放军总医院第一医学中心住院的高钙血症危象患者队列的回顾性分析。分析了患者的一般资料、临床表现、病因、影像学检查、急诊治疗、病因治疗及预后情况。
共纳入155例高钙血症危象患者(男性91例,女性64例),平均年龄54.60±16.99岁。导致高钙血症危象最常见的病因是甲状旁腺功能亢进(41.94%),其次是实体恶性肿瘤(41.29%)和多发性骨髓瘤(9.03%)等。患者主要表现为消化系统症状(78.10%)、神经系统症状(63.30%)、骨骼系统症状(59.60%)、泌尿系统症状(59.50%)和心血管系统症状(34.90%)。这155例高钙血症危象患者接受了有效的治疗,包括静脉输注等渗盐水、皮下注射降钙素、双膦酸盐,严重病例行血液透析。经过急诊治疗,患者所有症状均明显缓解。病因治疗后高钙血症的治愈率为84.50%(131/155)。
高钙血症危象是一种严重的内分泌急症,病因多样,死亡率高。及时诊断并实施全面有效的治疗可有效缓解这一内分泌急症。针对不同病因的病因治疗可显著改善预后。